Impact of Pharmacogenetic Variants in the University of Pennsylvania Health System

Impact of Pharmacogenetic Variants in the University of Pennsylvania Health System

Recipient of a Penn Center for Precision Medicine Accelerator Fund award in 2017, Sony Tuteja-Stevens, PharmD, MS, describes efforts to incorporate pharmacogenetics into clinical practice at Penn Medicine. A promising application, pharmacogenetics uses a patient’s genotype to predict drug responses and the risk of adverse effects.
A pharmacogenetics researcher, Dr. Tuteja-Stevens is a Research Associate in the Department of Translational Medicine & Human Genetics at Penn Medicine.

Related Links

Visit the Division of Translational Medicine & Human Genetics at Penn Medicine 

Personalized Diagnostics for Hematologic and Solid Tumor Cancers

 


Published

July 19, 2017

Created by

Penn Physician VideoLink